Epilepsy in time of COVID-19: A survey-based study.

Elena FonsecaManuel QuintanaSofía LallanaJuan Luis RestrepoLaura Abraira Estevo SantamarinaIván Seijo-RaposoManuel Toledo

Published in: Acta neurologica Scandinavica (2020)

The COVID-19 pandemic has effects in epilepsy patients. Patients with tumor-related, drug-resistant epilepsy, insomnia, and economic difficulties are at a higher risk of increased seizure frequency. Telemedicine represents a suitable tool in this setting.

Keyphrases

drug resistant
multidrug resistant
acinetobacter baumannii
end stage renal disease
coronavirus disease
ejection fraction
sars cov
newly diagnosed
prognostic factors
depressive symptoms
patient reported outcomes